Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-17T22:13:49.868Z Has data issue: false hasContentIssue false
  • English
  • Français

Cytochromes and psychotropic drug interactions

Published online by Cambridge University Press:  02 January 2018

G. D. L. Bates  and
A. E. Van Woerkom
G. D. L. Bates
Affiliation:
Parkview Clinic 60 Queensbridge Road Moseley Birmingham B13 8QE
A. E. Van Woerkom
Affiliation:
Queen Elizabeth Psychiatric Hospital Mindelsohn Way Birmingham B15 2TZ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 169 , Issue 5 , November 1996 , pp. 670
Copyright
Copyright © Royal College of Psychiatrists, 1996 

References

Arthur, H., Dahl, M. L., Siwers, B., et al (1995) Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia. Journal of Clinical Psychopharmacology, 15, 211–216.CrossRefGoogle ScholarPubMed
Bertilsson, L., Dahl, M. L., Sjoqvist, F., et al (1983) Molecular basis for rational megaprescriping in ultra rapid hydroxylators of debrisoquine. Lancet, 341, 63.CrossRefGoogle Scholar
Johansson, I., Lundqvist, E., Bertilsson, L., et al (1993) Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proceedings of the National Academy of Sciences USA, 90, 11825–11829.CrossRefGoogle ScholarPubMed
Taylor, D. & Lader, M. (1996) Cytochromes and psychotropic drug interactions. British Journal of Psychiatry, 168, 529–532.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.